HSCI Ventures, a company of the Human Stem Cell Institute group (HSCI, MOEX: ISKJ), has announced a change in its share of stock.
On April 27, 2023, HSCI Ventures sold 2,968,910 shares (3.58%) to Genetico at a market price of RUB 35 per share.
HSCI Ventures (ex Icegen 2) used to own 7.29% of Genetico’s shares. In 2020, HSCI Ventures purchased this share from RVC Biofund. According to HSCI’s director Sergey Masyuk, the decision to sell some of the shares was made by HSCI to stabilize the price of Genetico’s shares on the market.
In 2020, RVC Biofund sold its share in Genetico, making HSCI Ventures and Genetico’s founder Artur Isaev the ultimate owners.
On April 25, Genetico (Genetics and Reproductive Medicine Center, MOEX: GECO) held an IPO on the Moscow Exchange and raised RUB 178.8 million. The company offered 10 million shares (12% of the company’s capital). The order book was oversubscribed by 2.5 times.